Seventh Annual Symposium on Controversies and Clinical Challenges in Myeloma, Lymphoma, and Leukemia

Description

The optimal management of hematologic malignancies is rapidly evolving, with newly defined standards of care and the continuing emergence of more effective therapeutic regimens and novel agents. Many of these next-generation agents and ...